Abrams Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania

Abrams Cancer Center of the University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Abrams Cancer Center of the University of Pennsylvania has participated in 6 clinical trials.

Therapeutic areas: Glioma, Malignant, Glioblastoma, Gliosarcoma.

Sponsors: Candel Therapeutics, Inc., Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Basilea Pharmaceutica.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abrams Cancer Center of the University of Pennsylvania?

Abrams Cancer Center of the University of Pennsylvania has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abrams Cancer Center of the University of Pennsylvania conducted?

Abrams Cancer Center of the University of Pennsylvania has 6 clinical trials on record. Their work covers Glioma, Malignant, Glioblastoma, Gliosarcoma.

Is Abrams Cancer Center of the University of Pennsylvania accredited by Crixeo Health?

Yes — Abrams Cancer Center of the University of Pennsylvania holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Abrams Cancer Center of the University of Pennsylvania?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.